The field of drug discovery is inherently complex and plagued by high costs, long development times and high rates of failure. Artificial intelligence (AI) and automation have emerged as ...
When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics — the path to treatment is rarely straightforward. Filling a prescription can ...
Biotech and pharma greenhouse gas emissions are falling – but is current progress fast enough? Discover My Green Lab’s Impact ...
Royalty Pharma purchases royalties on pharmaceutical products. Diversification provides some protection for investors and the company has invested in high quality assets. Investors face risks ...
Quotient Sciences and Intrepid Labs have announced a multi-year strategic partnership to advance the use of artificial intelligence (AI) in early drug development.
- Alva10 joins DXRX global network to enable critical piece of end-to-end solution for developing and commercializing precision medicine diagnostics - Partnership will improve test coverage and ...
AbbVie is opening submissions for an award that will provide one Canadian biotech with free access to lab space and executive ...
—Walter Reed Army Institute of Research Will Use LabVantage Pharma LIMS to Support the Production of Vaccines for COVID-19 and Other Diseases— —LabVantage Pharma is the World’s Only Pre-Validated and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback